Stocks and Investing
Stocks and Investing
Thu, August 5, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
William Plovanic Maintained (ATRC) at Strong Buy with Increased Target to $120 on, Aug 5th, 2021
William Plovanic of Canaccord Genuity, Maintained "AtriCure, Inc." (ATRC) at Strong Buy with Increased Target from $102 to $120 on, Aug 5th, 2021.
William has made no other calls on ATRC in the last 4 months.
There is 1 other peer that has a rating on ATRC. Out of the 1 peers that are also analyzing ATRC, 0 agree with William's Rating of Hold.
This is the rating of the analyst that currently disagrees with William
- Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $81 on, Friday, May 14th, 2021
Contributing Sources